logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11440906 B1

PDFFull Text
Date of Patent:
Sep. 13, 2022

Filed:

Dec. 21, 2018

Biguanide derivatives and their rearrangement products for use in the treatment of cancer

Applicants:

Centre National DE LA Recherche Scientifique, Paris, FR;

Institut National DE LA Santé ET DE LA Recherche Médicale, Paris, FR;

Universite Cote D'azur, Nice, FR;

Inventors:

Rachid Benhida, Nice, FR;

Stephane Rocchi, Villefranche sur Mer, FR;

Cyril Ronco, Nice, FR;

Emile Jaune, Saint-Cannat, FR;

Oleksandr Grytsai, Nice, FR;

Nedra Tekaya, Nice, FR;

Assignees:

Centre National de la Recherche Scientifique, Paris, FR;

INSERM (Institut National de la Santé et de la Recherche Médicale), Paris, FR;

Université Côte d'Azur, Nice, FR;

Attorney:

WCF IP

Primary Examiner:

Laura L Stockton

Int. Cl.
CPC ...
C07D 251/48 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 405/04 (2006.01); C07D 409/04 (2006.01); A61P 35/00 (2006.01); C07D 409/14 (2006.01); C07D 277/48 (2006.01); C07D 277/82 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 417/12 (2006.01);
U.S. Cl.
CPC ...
C07D 409/14 (2013.01); A61P 35/00 (2018.01); C07D 251/48 (2013.01); C07D 277/48 (2013.01); C07D 277/82 (2013.01); C07D 401/04 (2013.01); C07D 403/04 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 405/04 (2013.01); C07D 409/04 (2013.01); C07D 417/12 (2013.01);
Abstract

The present disclosure relates to biguanide derivatives of formula (I) and their rearrangement products. The present disclosure also relates to the use of these compounds in a method for treating cancer, in particular melanoma.

Find Patent Forward Citations

Benhida, Rachid. (2022). Biguanide derivatives and their rearrangement products for use in the treatment of cancer (U.S. Patent No. 11440906). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11440906

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…